Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes for Redwood Pharma AB

Right Now

+/-
0.48
%
9,06%
Latest
5.78
High
5.84
Low
5.42
Volume
28 311
Turnover (SEK)
160 740
Value (MSEK)
72,2

Board

CEO

  • Martin Vidaeus

Chairman Of The Board

  • Gunnar Mattsson

Board

  • Hans Ageland
  • Ingrid Atteryd-Heiman
  • Martin Vidaeus
  • Mats Lidgard

Videos

Upcoming reports

  • 2019-05-07 Delårsrapport 2019-Q1

  • 2019-05-07 Årsstämma 2018

  • 2019-08-30 Delårsrapport 2019-Q2

  • 2019-11-19 Delårsrapport 2019-Q3

  • 2020-02-14 Bokslutskommuniké 2019